CRDF earnings: a negative outcome, -12.4%

On August 9, 2023, Cardiff Oncology, Inc. reached its earnings. The result was a negative outcome, and the stock moved -12.4% in the window around the event. It had already run +15.5% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.